FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Case sensitive SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym Active Case sensitive SNOMED CT model component

131244 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set Is a Historical association true Inferred relationship Some
Members associationTargetComponent
Aggrastat (tirofiban 12.5 mg / 250 mL) injection solution, 250 mL bag (trade product unit of use) Unknown Cell Type 2
Aggrastat (tirofiban 12.5 mg / 50 mL) concentrated injection, 1 x 50 mL vial (containered trade product pack) Unknown Cell Type 2
Aggrastat (tirofiban 12.5 mg / 50 mL) concentrated injection, 1 x 50 mL vial (trade product pack) Unknown Cell Type 2
Aggrastat (tirofiban 12.5 mg / 50 mL) concentrated injection, 50 mL vial (trade product unit of use) Unknown Cell Type 2
Aggrastat (tirofiban 25 mg / 500 mL) injection solution, 1 x 500 mL bag (containered trade product pack) Unknown Cell Type 2
Aggrastat (tirofiban 25 mg / 500 mL) injection solution, 1 x 500 mL bag (trade product pack) Unknown Cell Type 2
Aggrastat (tirofiban 25 mg / 500 mL) injection solution, 500 mL bag (trade product unit of use) Unknown Cell Type 2
Aggrastat 12.5 mg/250 mL injection solution, 250 mL bag Unknown Cell Type 2
Aggrastat 12.5 mg/250 mL injection solution, 250 mL bag Unknown Cell Type 2
Aggrastat 12.5 mg/250 mL injection solution, 250 mL bag Unknown Cell Type 2
Aggrastat 12.5 mg/50 mL concentrated injection, 50 mL vial Unknown Cell Type 2
Aggrastat 12.5 mg/50 mL concentrated injection, 50 mL vial Unknown Cell Type 2
Aggrastat 12.5 mg/50 mL concentrated injection, 50 mL vial Unknown Cell Type 2
Aggrastat 25 mg/500 mL injection solution, 500 mL bag Unknown Cell Type 2
Aggrastat 25 mg/500 mL injection solution, 500 mL bag Unknown Cell Type 2
Aggrastat 25 mg/500 mL injection solution, 500 mL bag Unknown Cell Type 2
Aggression caused by ingestible alcohol Aggression caused by ethanol
Agilocam (meloxicam 15 mg) hard capsule (trade product unit of use) Unknown Cell Type 2
Agilocam (meloxicam 15 mg) hard capsule, 30 capsules (trade product pack) Unknown Cell Type 2
Agilocam (meloxicam 15 mg) hard capsule, 30 capsules, blister pack (containered trade product pack) Unknown Cell Type 2
Agilocam (meloxicam 7.5 mg) hard capsule (trade product unit of use) Unknown Cell Type 2
Agilocam (meloxicam 7.5 mg) hard capsule, 30 capsules (trade product pack) Unknown Cell Type 2
Agilocam (meloxicam 7.5 mg) hard capsule, 30 capsules, blister pack (containered trade product pack) Unknown Cell Type 2
Agilocam 15 mg hard capsule Unknown Cell Type 2
Agilocam 15 mg hard capsule, 30 Unknown Cell Type 2
Agilocam 15 mg hard capsule, 30, blister pack Unknown Cell Type 2
Agilocam 7.5 mg hard capsule Unknown Cell Type 2
Agilocam 7.5 mg hard capsule, 30 Unknown Cell Type 2
Agilocam 7.5 mg hard capsule, 30, blister pack Unknown Cell Type 2
Agiolax granules Agiolax granules
Agiolax granules, 250 g Agiolax granules, 250 g
Agiolax granules, 250 g, jar Agiolax granules, 250 g, jar
Agomelatine (Ardix) (agomelatine 25 mg) film-coated tablet (trade product unit of use) Unknown Cell Type 2
Agomelatine (Ardix) (agomelatine 25 mg) film-coated tablet, 28 tablets (trade product pack) Unknown Cell Type 2
Agomelatine (Ardix) (agomelatine 25 mg) film-coated tablet, 28 tablets, blister pack (containered trade product pack) Unknown Cell Type 2
Agomelatine (Ardix) 25 mg film-coated tablet Unknown Cell Type 2
Agomelatine (Ardix) 25 mg film-coated tablet, 28 Unknown Cell Type 2
Agomelatine (Ardix) 25 mg film-coated tablet, 28, blister pack Unknown Cell Type 2
Agrippal 2011 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009 (NYMC X-187)) 15 microgram + B/Brisbane/60/2008-like strain (B/Brisbane/60/2008) 15 microgram) injection suspension, 0.5 mL syringe (trade product unit of use) Unknown Cell Type 2
Agrippal 2011 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009 (NYMC X-187)) 15 microgram + B/Brisbane/60/2008-like strain (B/Brisbane/60/2008) 15 microgram) injection suspension, 1 x 0.5 mL syringe (containered trade product pack) Unknown Cell Type 2
Agrippal 2011 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009 (NYMC X-187)) 15 microgram + B/Brisbane/60/2008-like strain (B/Brisbane/60/2008) 15 microgram) injection suspension, 1 x 0.5 mL syringe (trade product pack) Unknown Cell Type 2
Agrippal 2011 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009 (NYMC X-187)) 15 microgram + B/Brisbane/60/2008-like strain (B/Brisbane/60/2008) 15 microgram) injection suspension, 10 x 0.5 mL syringes (containered trade product pack) Unknown Cell Type 2
Agrippal 2011 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009 (NYMC X-187)) 15 microgram + B/Brisbane/60/2008-like strain (B/Brisbane/60/2008) 15 microgram) injection suspension, 10 x 0.5 mL syringes (trade product pack) Unknown Cell Type 2
Agrippal 2011 injection suspension, 0.5 mL syringe Unknown Cell Type 2
Agrippal 2011 injection suspension, 1 x 0.5 mL syringe Unknown Cell Type 2
Agrippal 2011 injection suspension, 1 x 0.5 mL syringe Unknown Cell Type 2
Agrippal 2011 injection suspension, 10 x 0.5 mL syringes Unknown Cell Type 2
Agrippal 2011 injection suspension, 10 x 0.5 mL syringes Unknown Cell Type 2
Agrippal 2012 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009 (NYMC X-187)) 15 microgram + B/Brisbane/60/2008-like strain (B/Brisbane/60/2008) 15 microgram) injection suspension, 0.5 mL syringe (trade product unit of use) Unknown Cell Type 2
Agrippal 2012 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009 (NYMC X-187)) 15 microgram + B/Brisbane/60/2008-like strain (B/Brisbane/60/2008) 15 microgram) injection suspension, 1 x 0.5 mL syringe (containered trade product pack) Unknown Cell Type 2
Agrippal 2012 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009 (NYMC X-187)) 15 microgram + B/Brisbane/60/2008-like strain (B/Brisbane/60/2008) 15 microgram) injection suspension, 1 x 0.5 mL syringe (trade product pack) Unknown Cell Type 2
Agrippal 2012 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009 (NYMC X-187)) 15 microgram + B/Brisbane/60/2008-like strain (B/Brisbane/60/2008) 15 microgram) injection suspension, 10 x 0.5 mL syringes (containered trade product pack) Unknown Cell Type 2
Agrippal 2012 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009 (NYMC X-187)) 15 microgram + B/Brisbane/60/2008-like strain (B/Brisbane/60/2008) 15 microgram) injection suspension, 10 x 0.5 mL syringes (trade product pack) Unknown Cell Type 2
Agrippal 2012 injection suspension, 0.5 mL syringe Unknown Cell Type 2
Agrippal 2012 injection suspension, 1 x 0.5 mL syringe Unknown Cell Type 2
Agrippal 2012 injection suspension, 1 x 0.5 mL syringe Unknown Cell Type 2
Agrippal 2012 injection suspension, 10 x 0.5 mL syringes Unknown Cell Type 2
Agrippal 2012 injection suspension, 10 x 0.5 mL syringes Unknown Cell Type 2
Agrippal 2013 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Victoria/361/2009 (H3N2)-like strain (A/Victoria/361/2011 (IVR-165)) 15 microgram + B/Wisconsin/1/2010-like strain (B/Hubei-Wujiagang/158/2009 (NYMC BX-39)) 15 microgram) injection suspension, 0.5 mL syringe (trade product unit of use) Unknown Cell Type 2
Agrippal 2013 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Victoria/361/2009 (H3N2)-like strain (A/Victoria/361/2011 (IVR-165)) 15 microgram + B/Wisconsin/1/2010-like strain (B/Hubei-Wujiagang/158/2009 (NYMC BX-39)) 15 microgram) injection suspension, 1 x 0.5 mL syringe (containered trade product pack) Unknown Cell Type 2
Agrippal 2013 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Victoria/361/2009 (H3N2)-like strain (A/Victoria/361/2011 (IVR-165)) 15 microgram + B/Wisconsin/1/2010-like strain (B/Hubei-Wujiagang/158/2009 (NYMC BX-39)) 15 microgram) injection suspension, 1 x 0.5 mL syringe (trade product pack) Unknown Cell Type 2
Agrippal 2013 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Victoria/361/2009 (H3N2)-like strain (A/Victoria/361/2011 (IVR-165)) 15 microgram + B/Wisconsin/1/2010-like strain (B/Hubei-Wujiagang/158/2009 (NYMC BX-39)) 15 microgram) injection suspension, 10 x 0.5 mL syringes (containered trade product pack) Unknown Cell Type 2
Agrippal 2013 (A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 15 microgram + A/Victoria/361/2009 (H3N2)-like strain (A/Victoria/361/2011 (IVR-165)) 15 microgram + B/Wisconsin/1/2010-like strain (B/Hubei-Wujiagang/158/2009 (NYMC BX-39)) 15 microgram) injection suspension, 10 x 0.5 mL syringes (trade product pack) Unknown Cell Type 2
Agrippal 2013 injection suspension, 0.5 mL syringe Unknown Cell Type 2
Agrippal 2013 injection suspension, 1 x 0.5 mL syringe Unknown Cell Type 2
Agrippal 2013 injection suspension, 1 x 0.5 mL syringe Unknown Cell Type 2
Agrippal 2013 injection suspension, 10 x 0.5 mL syringes Unknown Cell Type 2
Agrippal 2013 injection suspension, 10 x 0.5 mL syringes Unknown Cell Type 2
Agrippal 2014 (A/California/7/2009 (H1N1) (NYMC X-179A) (A/California/7/2009 (H1N1)pdm09-like) inactivated vaccine 15 microgram + A/Texas/50/2012 (NYMC X-223A) (A/Texas/50/2012 (H3N2)-like) inactivated vaccine 15 microgram + B/Massachusetts/2/2012 (NYMC BX-51B) (B/Massachusetts/2/2012-like) inactivated vaccine 15 microgram) injection suspension, 0.5 mL syringe (trade product unit of use) Unknown Cell Type 2
Agrippal 2014 (A/California/7/2009 (H1N1) (NYMC X-179A) (A/California/7/2009 (H1N1)pdm09-like) inactivated vaccine 15 microgram + A/Texas/50/2012 (NYMC X-223A) (A/Texas/50/2012 (H3N2)-like) inactivated vaccine 15 microgram + B/Massachusetts/2/2012 (NYMC BX-51B) (B/Massachusetts/2/2012-like) inactivated vaccine 15 microgram) injection suspension, 1 x 0.5 mL syringe (containered trade product pack) Unknown Cell Type 2
Agrippal 2014 (A/California/7/2009 (H1N1) (NYMC X-179A) (A/California/7/2009 (H1N1)pdm09-like) inactivated vaccine 15 microgram + A/Texas/50/2012 (NYMC X-223A) (A/Texas/50/2012 (H3N2)-like) inactivated vaccine 15 microgram + B/Massachusetts/2/2012 (NYMC BX-51B) (B/Massachusetts/2/2012-like) inactivated vaccine 15 microgram) injection suspension, 1 x 0.5 mL syringe (trade product pack) Unknown Cell Type 2
Agrippal 2014 (A/California/7/2009 (H1N1) (NYMC X-179A) (A/California/7/2009 (H1N1)pdm09-like) inactivated vaccine 15 microgram + A/Texas/50/2012 (NYMC X-223A) (A/Texas/50/2012 (H3N2)-like) inactivated vaccine 15 microgram + B/Massachusetts/2/2012 (NYMC BX-51B) (B/Massachusetts/2/2012-like) inactivated vaccine 15 microgram) injection suspension, 10 x 0.5 mL syringes (containered trade product pack) Unknown Cell Type 2
Agrippal 2014 (A/California/7/2009 (H1N1) (NYMC X-179A) (A/California/7/2009 (H1N1)pdm09-like) inactivated vaccine 15 microgram + A/Texas/50/2012 (NYMC X-223A) (A/Texas/50/2012 (H3N2)-like) inactivated vaccine 15 microgram + B/Massachusetts/2/2012 (NYMC BX-51B) (B/Massachusetts/2/2012-like) inactivated vaccine 15 microgram) injection suspension, 10 x 0.5 mL syringes (trade product pack) Unknown Cell Type 2
Agrippal 2014 injection suspension, 0.5 mL syringe Unknown Cell Type 2
Agrippal 2014 injection suspension, 1 x 0.5 mL syringe Unknown Cell Type 2
Agrippal 2014 injection suspension, 1 x 0.5 mL syringe Unknown Cell Type 2
Agrippal 2014 injection suspension, 10 x 0.5 mL syringes Unknown Cell Type 2
Agrippal 2014 injection suspension, 10 x 0.5 mL syringes Unknown Cell Type 2
Agrippal 2015 (A/California/7/2009 (H1N1)-like virus 15 microgram + A/Switzerland/9715293/2013 (H3N2)-like virus 15 microgram + B/Phuket/3073/2013-like virus 15 microgram) injection suspension, 0.5 mL syringe (trade product unit of use) Unknown Cell Type 2
Agrippal 2015 (A/California/7/2009 (H1N1)-like virus 15 microgram + A/Switzerland/9715293/2013 (H3N2)-like virus 15 microgram + B/Phuket/3073/2013-like virus 15 microgram) injection suspension, 1 x 0.5 mL syringe (containered trade product pack) Unknown Cell Type 2
Agrippal 2015 (A/California/7/2009 (H1N1)-like virus 15 microgram + A/Switzerland/9715293/2013 (H3N2)-like virus 15 microgram + B/Phuket/3073/2013-like virus 15 microgram) injection suspension, 1 x 0.5 mL syringe (trade product pack) Unknown Cell Type 2
Agrippal 2015 (A/California/7/2009 (H1N1)-like virus 15 microgram + A/Switzerland/9715293/2013 (H3N2)-like virus 15 microgram + B/Phuket/3073/2013-like virus 15 microgram) injection suspension, 10 x 0.5 mL syringes (containered trade product pack) Unknown Cell Type 2
Agrippal 2015 (A/California/7/2009 (H1N1)-like virus 15 microgram + A/Switzerland/9715293/2013 (H3N2)-like virus 15 microgram + B/Phuket/3073/2013-like virus 15 microgram) injection suspension, 10 x 0.5 mL syringes (trade product pack) Unknown Cell Type 2
Agrippal 2015 injection suspension, 0.5 mL syringe Unknown Cell Type 2
Agrippal 2015 injection suspension, 1 x 0.5 mL syringe Unknown Cell Type 2
Agrippal 2015 injection suspension, 1 x 0.5 mL syringe Unknown Cell Type 2
Agrippal 2015 injection suspension, 10 x 0.5 mL syringes Unknown Cell Type 2
Agrippal 2015 injection suspension, 10 x 0.5 mL syringes Unknown Cell Type 2
Agrobacterium radiobacter Rhizobium radiobacter
Agrobacterium tumefaciens Rhizobium radiobacter
Agrylin 500 microgram capsule Agrylin 500 microgram capsule
Agrylin 500 microgram capsule, 100 Agrylin 500 microgram capsule, 100
Agrylin 500 microgram capsule, 100, bottle Agrylin 500 microgram capsule, 100, bottle
Agtolac (metoprolol tartrate 5 mg / 5 mL) injection solution, 5 mL vial (trade product unit of use) Unknown Cell Type 2
Agtolac (metoprolol tartrate 5 mg / 5 mL) injection solution, 5 x 5 mL vials (containered trade product pack) Unknown Cell Type 2
Agtolac (metoprolol tartrate 5 mg / 5 mL) injection solution, 5 x 5 mL vials (trade product pack) Unknown Cell Type 2
Agtolac 5 mg/5 mL injection solution, 5 mL vial Unknown Cell Type 2
Agtolac 5 mg/5 mL injection solution, 5 x 5 mL vials Unknown Cell Type 2
Agtolac 5 mg/5 mL injection solution, 5 x 5 mL vials Unknown Cell Type 2
Ahmed tube shunt Valved ophthalmic drainage device
Aids for severely handicapped Provision of aid for severe disability

Start Previous Page 36 of 1313 Next End

Reference Sets

Australian dialect reference set

Unit of use quantity reference set

Reference set descriptor

Back to Start